12-Month Lobbying Summary - In-house Corporation

Medicago Inc / Toshifumi Tada, President and Chief Executive Officer

Registration Summary

Inactive - Activity Ended: 2023-05-01

Who is lobbying?

Medicago Inc (Address & business activities)

Toshifumi Tada, President and Chief Executive Officer

Received government funding or funding expected in current financial year

Yes

Business Relationships

Medicago Inc is a subsidiary of the following parent companies

Mitsubishi Tanabe Pharma Corporation (Address information)

Beneficiaries of the Lobbying Activity

Medicago Inc has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Medicago R&D Inc (Address information)
Medicago USA (Address information)

What is being lobbied?

Subject Matters

Health
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Obtain financial support from the Federal Government regarding research and development activities

Policies or Program

Advocacy to maintain and increase funding for the National Immunization Strategy.
Discussions on Canada’s procurement policies related to vaccines, in particular as it relates to Medicago’s COVID-19 vaccine candidate.
To actively promote the value of the pharmaceutical industry for Canada's economy, including through policies that will attract increased investment in the pharmaceutical industry.

Who is being lobbied?

Government Institutions

Canada Economic Development for Quebec Regions
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Senate of Canada

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Grass-roots communication
Oral communication
Written communication

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Toshifumi Tada, President and Chief Executive Officer | No public offices held
Nicolas Petit, Vice President, Commercial Operations | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Registration number: 952231-370653
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

No monthly communications reports have been submitted for the last 12 months.

View all monthly communication reports

End date of the last completed financial year: 2022-03-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Innovation, Science and Economic Development Canada (ISED)	$89,625,000.00	Yes
National Research Council (NRC)	No	Yes

Date Modified:: 2024-04-04

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

Medicago Inc / Toshifumi Tada, President and Chief Executive Officer

Who is lobbying?

Medicago Inc (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Medicago Inc is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

Medicago Inc has the following subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Policies or Program

Who is being lobbied?

Government Institutions

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

What oral and arranged communications have taken place?

12-Month Lobbying Summary - In-house Corporation

Medicago Inc / Toshifumi Tada, President and Chief Executive Officer

Medicago Inc (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Medicago Inc is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

Medicago Inc has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Policies or Program

Government Institutions

Communication techniques

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Medicago Inc - Address & business activities

Mitsubishi Tanabe Pharma Corporation

Medicago USA

Medicago R&D Inc